The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feldmesser, M.
Right arrow Articles by Casadevall, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feldmesser, M.
Right arrow Articles by Casadevall, A.

The Journal of Immunology, Vol 158, Issue 2 790-799, Copyright © 1997 by American Association of Immunologists


ARTICLES

Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection

M Feldmesser and A Casadevall
Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

Little is known about the role of Ab in protection against pulmonary fungal pathogens. The ability of murine IgG1 mAb 2H1 to modify pulmonary Cryptococcus neoformans infection was investigated in intratracheal infection. mAb 2H1 binds C. neoformans glucuronoxylomannan. mAb 2H1 was given to A/JCr mice 24 h before infection. Two C. neoformans strains were studied: ATCC 24067 (serotype D) and 62070 (serotype A). Fungal burden was determined by CFU 14 days after infection for both strains, and at 2 h, 24 h, 48 h, 7 days, and 28 days after infection for strain 24067. On day 14, mAb 2H1 treatment reduced CFU in the lung, brain, and liver for strain 62070 infection. Minor reductions in lung CFU followed infection with strain 24067 in mAb 2H1-treated mice, despite prolonged survival. The limited ability of mAb 2H1 to reduce lung CFU may reflect rapid phagocytosis of yeast by alveolar macrophages, seen by electron microscopy 2 h after infection, regardless of whether mice had received mAb. Alveolar macrophages phagocytosed and reduced C. neoformans CFU in vitro only in the presence of mAb 2H1. Differences were apparent in phagocytosis and in vitro killing between strains 24067 and 62070. Serum IgG1 modified the course of pulmonary infection in mice by prolonging survival, reducing CFU, and reducing tissue glucuronoxylomannan Ag. mAb administration was associated with enhanced granulomatous inflammation, but did not prevent infection or dissemination. Despite incomplete protection by serum Ab against pulmonary infection, our results provide encouragement for continued vaccine development.


This article has been cited by other articles:


Home page
CVIHome page
K. Datta, A. Lees, and L.-a. Pirofski
Therapeutic Efficacy of a Conjugate Vaccine Containing a Peptide Mimotope of Cryptococcal Capsular Polysaccharide Glucuronoxylomannan
Clin. Vaccine Immunol., August 1, 2008; 15(8): 1176 - 1187.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
M. L. Rodrigues, L. Shi, E. Barreto-Bergter, L. Nimrichter, S. E. Farias, E. G. Rodrigues, L. R. Travassos, and J. D. Nosanchuk
Monoclonal Antibody to Fungal Glucosylceramide Protects Mice against Lethal Cryptococcus neoformans Infection
Clin. Vaccine Immunol., October 1, 2007; 14(10): 1372 - 1376.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. C. McFadden, M. De Jesus, and A. Casadevall
The Physical Properties of the Capsular Polysaccharides from Cryptococcus neoformans Suggest Features for Capsule Construction
J. Biol. Chem., January 27, 2006; 281(4): 1868 - 1875.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Shao, A. Mednick, M. Alvarez, N. van Rooijen, A. Casadevall, and D. L. Goldman
An Innate Immune System Cell Is a Major Determinant of Species-Related Susceptibility Differences to Fungal Pneumonia
J. Immunol., September 1, 2005; 175(5): 3244 - 3251.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Rivera and A. Casadevall
Mouse Genetic Background Is a Major Determinant of Isotype-Related Differences for Antibody-Mediated Protective Efficacy against Cryptococcus neoformans
J. Immunol., June 15, 2005; 174(12): 8017 - 8026.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. J. Mednick, J. D. Nosanchuk, and A. Casadevall
Melanization of Cryptococcus neoformans Affects Lung Inflammatory Responses during Cryptococcal Infection
Infect. Immun., April 1, 2005; 73(4): 2012 - 2019.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
R. A. Larsen, P. G. Pappas, J. Perfect, J. A. Aberg, A. Casadevall, G. A. Cloud, R. James, S. Filler, and W. E. Dismukes
Phase I Evaluation of the Safety and Pharmacokinetics of Murine-Derived Anticryptococcal Antibody 18B7 in Subjects with Treated Cryptococcal Meningitis
Antimicrob. Agents Chemother., March 1, 2005; 49(3): 952 - 958.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. Rivera, O. Zaragoza, and A. Casadevall
Antibody-Mediated Protection against Cryptococcus neoformans Pulmonary Infection Is Dependent on B Cells
Infect. Immun., February 1, 2005; 73(2): 1141 - 1150.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
B. C. Fries, E. Cook, X. Wang, and A. Casadevall
Effects of Antifungal Interventions on the Outcome of Experimental Infections with Phenotypic Switch Variants of Cryptococcus neoformans
Antimicrob. Agents Chemother., January 1, 2005; 49(1): 350 - 357.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. D. Stephens-Romero, A. J. Mednick, and M. Feldmesser
The Pathogenesis of Fatal Outcome in Murine Pulmonary Aspergillosis Depends on the Neutrophil Depletion Strategy
Infect. Immun., January 1, 2005; 73(1): 114 - 125.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Casadevall and L.-a. Pirofski
New Concepts in Antibody-Mediated Immunity
Infect. Immun., November 1, 2004; 72(11): 6191 - 6196.
[Full Text] [PDF]


Home page
Eukaryot CellHome page
M. Del Poeta
Role of Phagocytosis in the Virulence of Cryptococcus neoformans
Eukaryot. Cell, October 1, 2004; 3(5): 1067 - 1075.
[Full Text] [PDF]


Home page
Infect. Immun.Home page
O. Zaragoza and A. Casadevall
Antibodies Produced in Response to Cryptococcus neoformans Pulmonary Infection in Mice Have Characteristics of Nonprotective Antibodies
Infect. Immun., July 1, 2004; 72(7): 4271 - 4274.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
T. Burns, Z. Zhong, M. Steinitz, and L.-a. Pirofski
Modulation of Polymorphonuclear Cell Interleukin-8 Secretion by Human Monoclonal Antibodies to Type 8 Pneumococcal Capsular Polysaccharide
Infect. Immun., December 1, 2003; 71(12): 6775 - 6783.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
D. de Mattos Grosso, S. R. de Almeida, M. Mariano, and J. D. Lopes
Characterization of gp70 and Anti-gp70 Monoclonal Antibodies in Paracoccidioides brasiliensis Pathogenesis
Infect. Immun., November 1, 2003; 71(11): 6534 - 6542.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Dadachova, A. Nakouzi, R. A. Bryan, and A. Casadevall
Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection
PNAS, September 16, 2003; 100(19): 10942 - 10947.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Vecchiarelli, D. Pietrella, P. Lupo, F. Bistoni, D. C. McFadden, and A. Casadevall
The polysaccharide capsule of Cryptococcus neoformans interferes with human dendritic cell maturation and activation
J. Leukoc. Biol., September 1, 2003; 74(3): 370 - 378.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Casadevall
Antibody-Mediated Immunity against Intracellular Pathogens: Two-Dimensional Thinking Comes Full Circle
Infect. Immun., August 1, 2003; 71(8): 4225 - 4228.
[Full Text] [PDF]


Home page
J. Immunol.Home page
C. P. Taborda, J. Rivera, O. Zaragoza, and A. Casadevall
More Is Not Necessarily Better: Prozone-Like Effects in Passive Immunization with IgG
J. Immunol., April 1, 2003; 170(7): 3621 - 3630.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
W. He, A. Casadevall, S. C. Lee, and D. L. Goldman
Phagocytic Activity and Monocyte Chemotactic Protein Expression by Pulmonary Macrophages in Persistent Pulmonary Cryptococcosis
Infect. Immun., February 1, 2003; 71(2): 930 - 936.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
D. van Duin, A. Casadevall, and J. D. Nosanchuk
Melanization of Cryptococcus neoformans and Histoplasma capsulatum Reduces Their Susceptibilities to Amphotericin B and Caspofungin
Antimicrob. Agents Chemother., November 1, 2002; 46(11): 3394 - 3400.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Shapiro, D. O. Beenhouwer, M. Feldmesser, C. Taborda, M. C. Carroll, A. Casadevall, and M. D. Scharff
Immunoglobulin G Monoclonal Antibodies to Cryptococcus neoformans Protect Mice Deficient in Complement Component C3
Infect. Immun., May 1, 2002; 70(5): 2598 - 2604.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Rivera, J. Mukherjee, L. M. Weiss, and A. Casadevall
Antibody Efficacy in Murine Pulmonary Cryptococcus neoformans Infection: A Role for Nitric Oxide
J. Immunol., April 1, 2002; 168(7): 3419 - 3427.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. C. Tucker and A. Casadevall
Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm
PNAS, March 5, 2002; 99(5): 3165 - 3170.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Feldmesser, A. Mednick, and A. Casadevall
Antibody-Mediated Protection in Murine Cryptococcus neoformans Infection Is Associated with Pleotrophic Effects on Cytokine and Leukocyte Responses
Infect. Immun., March 1, 2002; 70(3): 1571 - 1580.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. Retini, T. R. Kozel, D. Pietrella, C. Monari, F. Bistoni, and A. Vecchiarelli
Interdependency of Interleukin-10 and Interleukin-12 in Regulation of T-Cell Differentiation and Effector Function of Monocytes in Response to Stimulation with Cryptococcus neoformans
Infect. Immun., October 1, 2001; 69(10): 6064 - 6073.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
M. Feldmesser, Y. Kress, and A. Casadevall
Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection
Microbiology, August 1, 2001; 147(8): 2355 - 2365.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Feldmesser, Y. Kress, and A. Casadevall
Intracellular Crystal Formation as a Mechanism of Cytotoxicity in Murine Pulmonary Cryptococcus neoformans Infection
Infect. Immun., April 1, 2001; 69(4): 2723 - 2727.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
D. Goldman, X. Song, R. Kitai, A. Casadevall, M.-L. Zhao, and S. C. Lee
Cryptococcus neoformans Induces Macrophage Inflammatory Protein 1{alpha} (MIP-1{alpha}) and MIP-1{beta} in Human Microglia: Role of Specific Antibody and Soluble Capsular Polysaccharide
Infect. Immun., March 1, 2001; 69(3): 1808 - 1815.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. P. Taborda and A. Casadevall
Immunoglobulin M Efficacy Against Cryptococcus neoformans: Mechanism, Dose Dependence, and Prozone-Like Effects in Passive Protection Experiments
J. Immunol., February 1, 2001; 166(3): 2100 - 2107.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Feldmesser, Y. Kress, P. Novikoff, and A. Casadevall
Cryptococcus neoformans Is a Facultative Intracellular Pathogen in Murine Pulmonary Infection
Infect. Immun., July 1, 2000; 68(7): 4225 - 4237.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Feldmesser, J. Rivera, Y. Kress, T. R. Kozel, and A. Casadevall
Antibody Interactions with the Capsule of Cryptococcus neoformans
Infect. Immun., June 1, 2000; 68(6): 3642 - 3650.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. L. Rosas, J. D. Nosanchuk, M. Feldmesser, G. M. Cox, H. C. McDade, and A. Casadevall
Synthesis of Polymerized Melanin by Cryptococcus neoformans in Infected Rodents
Infect. Immun., May 1, 2000; 68(5): 2845 - 2853.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. C. MacGill, R. S. MacGill, A. Casadevall, and T. R. Kozel
Biological Correlates of Capsular (Quellung) Reactions of Cryptococcus neoformans
J. Immunol., May 1, 2000; 164(9): 4835 - 4842.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
D. L. Goldman, S. C. Lee, A. J. Mednick, L. Montella, and A. Casadevall
Persistent Cryptococcus neoformans Pulmonary Infection in the Rat Is Associated with Intracellular Parasitism, Decreased Inducible Nitric Oxide Synthase Expression, and Altered Antibody Responsiveness to Cryptococcal Polysaccharide
Infect. Immun., February 1, 2000; 68(2): 832 - 838.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. A. Lovchik, J. A. Wilder, G. B. Huffnagle, R. Riblet, C. R. Lyons, and M. F. Lipscomb
Ig Heavy Chain Complex-Linked Genes Influence the Immune Response in a Murine Cryptococcal Infection
J. Immunol., October 1, 1999; 163(7): 3907 - 3913.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
G. Nussbaum, S. Anandasabapathy, J. Mukherjee, M. Fan, A. Casadevall, and M. D. Scharff
Molecular and Idiotypic Analyses of the Antibody Response to Cryptococcus neoformans Glucuronoxylomannan-Protein Conjugate Vaccine in Autoimmune and Nonautoimmune Mice
Infect. Immun., September 1, 1999; 67(9): 4469 - 4476.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
R. M. Syme, T. F. Bruno, T. R. Kozel, and C. H. Mody
The Capsule of Cryptococcus neoformans Reduces T-Lymphocyte Proliferation by Reducing Phagocytosis, Which Can Be Restored with Anticapsular Antibody
Infect. Immun., September 1, 1999; 67(9): 4620 - 4627.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
L.-C. Chen and A. Casadevall
Variants of a Cryptococcus neoformans Strain Elicit Different Inflammatory Responses in Mice
Clin. Vaccine Immunol., March 1, 1999; 6(2): 266 - 268.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. M. Levitz, S.-H. Nong, K. F. Seetoo, T. S. Harrison, R. A. Speizer, and E. R. Simons
Cryptococcus neoformans Resides in an Acidic Phagolysosome of Human Macrophages
Infect. Immun., February 1, 1999; 67(2): 885 - 890.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Retini, A. Casadevall, D. Pietrella, C. Monari, B. Palazzetti, and A. Vecchiarelli
Specific Activated T Cells Regulate IL-12 Production by Human Monocytes Stimulated with Cryptococcus neoformans
J. Immunol., February 1, 1999; 162(3): 1618 - 1623.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. D. Nosanchuk, P. Valadon, M. Feldmesser, and A. Casadevall
Melanization of Cryptococcus neoformans in Murine Infection
Mol. Cell. Biol., January 1, 1999; 19(1): 745 - 750.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Teitelbaum, A. Glatman-Freedman, B. Chen, J. B. Robbins, E. Unanue, A. Casadevall, and B. R. Bloom
A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival
PNAS, December 22, 1998; 95(26): 15688 - 15693.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Y. Han, R. P. Morrison, and J. E. Cutler
A Vaccine and Monoclonal Antibodies That Enhance Mouse Resistance to Candida albicans Vaginal Infection
Infect. Immun., December 1, 1998; 66(12): 5771 - 5776.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Wuthrich, W.-l. Chang, and B. S. Klein
Immunogenicity and Protective Efficacy of the WI-1 Adhesin of Blastomyces dermatitidis
Infect. Immun., November 1, 1998; 66(11): 5443 - 5449.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. Rivera, M. Feldmesser, M. Cammer, and A. Casadevall
Organ-Dependent Variation of Capsule Thickness in Cryptococcus neoformans during Experimental Murine Infection
Infect. Immun., October 1, 1998; 66(10): 5027 - 5030.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Mukherjee, T. R. Kozel, and A. Casadevall
Monoclonal Antibodies Reveal Additional Epitopes of Serotype D Cryptococcus neoformans Capsular Glucuronoxylomannan that Elicit Protective Antibodies
J. Immunol., October 1, 1998; 161(7): 3557 - 3568.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
A. Casadevall, W. Cleare, M. Feldmesser, A. Glatman-Freedman, D. L. Goldman, T. R. Kozel, N. Lendvai, J. Mukherjee, L.-a. Pirofski, J. Rivera, et al.
Characterization of a Murine Monoclonal Antibody to Cryptococcus neoformans Polysaccharide That Is a Candidate for Human Therapeutic Studies
Antimicrob. Agents Chemother., June 1, 1998; 42(6): 1437 - 1446.
[Abstract] [Full Text]


Home page
Infect. Immun.Home page
R. R. Yuan, G. Spira, J. Oh, M. Paizi, A. Casadevall, and M. D. Scharff
Isotype Switching Increases Efficacy of Antibody Protection against Cryptococcus neoformans Infection in Mice
Infect. Immun., March 1, 1998; 66(3): 1057 - 1062.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Vecchiarelli, C. Retini, C. Monari, and A. Casadevall
Specific Antibody to Cryptococcus neoformans Alters Human Leukocyte Cytokine Synthesis and Promotes T-Cell Proliferation
Infect. Immun., March 1, 1998; 66(3): 1244 - 1247.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. B. Huffnagle, M. B. Boyd, N. E. Street, and M. F. Lipscomb
IL-5 Is Required for Eosinophil Recruitment, Crystal Deposition, and Mononuclear Cell Recruitment During a Pulmonary Cryptococcus neoformans Infection in Genetically Susceptible Mice (C57BL/6)
J. Immunol., March 1, 1998; 160(5): 2393 - 2400.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. P. Franzot, J. Mukherjee, R. Cherniak, L.-C. Chen, J. S. Hamdan, and A. Casadevall
Microevolution of a Standard Strain of Cryptococcus neoformans Resulting in Differences in Virulence and Other Phenotypes
Infect. Immun., January 1, 1998; 66(1): 89 - 97.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.